EPAM Systems Reports 15.4% Revenue Growth, Authorizes New $1.0 Billion Share Repurchase Program
summarizeSummary
EPAM Systems reported 15.4% revenue growth for 2025, alongside a decline in net income and diluted EPS, while authorizing a new $1.0 billion share repurchase program.
check_boxKey Events
-
Strong Revenue Growth
Total revenues increased by 15.4% to $5.457 billion in 2025, driven by acquisitions and increased demand from existing clients across various industries.
-
New $1.0 Billion Share Repurchase Program
The Board of Directors authorized a new share repurchase program for up to $1.0 billion of common stock, replacing the exhausted $500 million 2024 program. The company repurchased $660.6 million in shares during 2025.
-
Decline in Net Income and EPS
Net income decreased to $377.7 million in 2025 from $454.5 million in 2024, and diluted EPS fell to $6.72 from $7.84, reflecting increased operating expenses.
-
Cost Optimization Initiatives
The company initiated a 2025 Cost Optimization Program, including workforce reductions, with an expected $25.0 million in additional charges, aiming to improve utilization and profitability.
auto_awesomeAnalysis
EPAM Systems' annual report reveals a mixed financial performance for 2025, with robust revenue growth driven by acquisitions and increased client demand, but a decline in net income and diluted EPS. The company is actively managing its capital structure by authorizing a substantial new $1.0 billion share repurchase program, following the exhaustion of its previous program. This significant capital return initiative, alongside ongoing cost optimization efforts and a favorable tax law change, indicates management's focus on shareholder value and operational efficiency despite profitability pressures. Investors should monitor the impact of the cost optimization program on future earnings and the execution of the share repurchase.
At the time of this filing, EPAM was trading at $138.62 on NYSE in the Technology sector, with a market capitalization of approximately $7.7B. The 52-week trading range was $125.57 to $222.53. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.